This document discusses herbal antimicrobials as an alternative to conventional antibiotics to address antimicrobial resistance (AMR). It provides information on the scope of AMR globally, including an estimated 1.27 million deaths directly attributable to resistance in 2019. The document then summarizes research on the antimicrobial properties of various herbs and oils, including carvacrol, ajowan oil, thyme oil, and cinnamaldehyde. It presents data on the susceptibility of different bacterial strains to these herbal antimicrobials. The document concludes by acknowledging limitations to the therapeutic use of herbal antimicrobials, such as a lack of quality control and defined therapeutic doses, but also their potential to be effective antimicrobial treatments.
Bangalore Call Girls Majestic š 9907093804 High Profile Service 100% Safe
Ā
Herbal Antimicrobials May Help Combat AMR
1. Herbal Antimicrobials to Counter
AMR: An exploratory study
Bhoj R Singh
Principal Scientist and Head
Division of Epidemiology, ICAR-IVRI, Izatnagar-243122
Lecture on 21st February 2023. In: Antimicrobial Resistance (AMR) in Foodborne pathogensā sponsored
under the ICAR-NAHEP-CAAST project by the MAFSU, Mumbai Veterinary College, at the Division of
Veterinary Public Health, ICAR-IVRI from 20th February to 25th February, 2023.
2. Antimicrobial Drug-resistance (AMR)
As per the latest meta-analysis (https://doi.org/10.1016/S0140-6736) by Dr
Mohsen Naghavi, Institute for Health Metrics and Evaluation,
University of Washington, Seattle, WA 98195, USA nagham@uw.edu
ā¢ 1Ā·27 million deaths were directly attributable to resistance in 2019.
ā¢ 4Ā·95 million deaths were associated with bacteria
ā¢ Australasia had the lowest AMR burden in 2019, with 6Ā·5 deaths per 100
000 attributable to AMR and 28Ā·0 deaths per 100 000 associated with AMR
in 2019.
ā¢ Western sub-Saharan Africa had the highest burden, with 27Ā·3 deaths per
100 000 attributable to AMR and 114Ā·8 deaths per 100 000 associated with
AMR in 2019.
ā¢ Lower respiratory and thorax infections, bloodstream infections, and intra-
abdominal infections accounted for 78Ā·8 of the deaths attributable to AMR
in 2019; lower respiratory infections alone accounted for more than 400
000 attributable deaths and 1Ā·5 million associated deaths.
3. All-age rate of deaths attributable to and associated with bacterial antimicrobial
resistance by Global Burden of Disease (GBD) region, 2019
Estimates were aggregated across drugs, accounting for the co-occurrence of
resistance to multiple drugs. Error bars show 95% uncertainty intervals. GBD=Global
Burden of Diseases, Injuries, and Risk Factors Study.
4. Global deaths (counts) attributable to and associated with bacterial antimicrobial resistance by
infectious syndrome, 2019
Estimates were aggregated across drugs, accounting for the co-occurrence of resistance to multiple
drugs. Error bars show 95% uncertainty intervals. Does not include gonorrhoea and chlamydia
because we did not estimate the fatal burden of this infectious syndrome. Bone+=infections of
bones, joints, and related organs. BSI=bloodstream infections. Cardiac=endocarditis and other
cardiac infections. CNS=meningitis and other bacterial CNS infections. Intra-abdominal=peritoneal
and intra-abdominal infections. LRI+=lower respiratory infections and all related infections in the
thorax. Skin=bacterial infections of the skin and subcutaneous systems. TFāPFāiNTS= typhoid fever,
paratyphoid fever, and invasive non-typhoidal Salmonella spp. UTI=urinary tract infections and
pyelonephritis.
5. AMR Pathogens
The six leading pathogens for deaths associated with resistance included
Escherichia coli, followed by Staphylococcus aureus, Klebsiella
pneumoniae, Streptococcus pneumoniae, Acinetobacter baumannii, and
Pseudomonas aeruginosa.
The six pathogens were responsible for 929 000 (660 000ā1 270 000) deaths
attributable to AMR and 3Ā·57 million (2Ā·62ā4Ā·78) deaths associated with
AMR in 2019.
Of the leading AMR pathogen-drug combinations, meticillin-resistant S.
aureus (MRSA), resistance was generally highest (60% to less than 80%) in
countries in north Africa and the Middle East (e.g., Iraq and Kuwait) and
lowest (less than 5%) in several countries in Europe and sub-Saharan
Africa. MRSA was responsible for more than 100,000 deaths and 3Ā·5
million cases attributable to resistance
The isoniazid and rifampicin co-resistant (MDR excluding XDR) M.
tuberculosis, isolate resistance was highest (primarily 10% to less than
30%) in eastern Europe and under 5% in many countries around the world.
The other five groups are third-generation cephalosporin-resistant E. coli,
carbapenem-resistant A. baumannii, fluoroquinolone-resistant E. coli,
carbapenem-resistant K. pneumoniae, and third-generation
cephalosporin-resistant K. pneumoniae.
6. Global deaths (counts) attributable to and associated with bacterial antimicrobial
resistance by pathogen types, 2019
Estimates were aggregated across drugs, accounting for the co-occurrence of
resistance to multiple drugs. Error bars show 95% uncertainty intervals.
7. Therefore
ā¢ There is an urgent need to develop therapeutic interventions for the
treatment of AMR infections.
ā¢ Development of strong antimicrobial stewardship.
ā¢ Developing the modern tools using scientific innovations in, biology,
genomics and proteomics to mitigate AMR pathogens
ā¢ Search for new antibiotics
ā¢ Development and strengthening of the use of conventional alternatives
to antibiotics
ā Chemical antimicrobials (also called biocides and antimicrobial pesticides) are often
used as antiseptics, disinfectants, and sterilizers, sanitisers
ā¢ Organic
ā¢ Inorganic
ā Herbal antimicrobials
ā Antiserum- Serum therapy & Monoclonal antibodies
ā Vaccines: Not to discuss
ā Repurposing the drugs
ā Homeopathy
ā Acupuncture and Acupressure
ā Bhabhut/ Ashes/ Fumes/ Mantras
8. Scope of alternate antimicrobials
Globally about 35 billion doses of antibiotics (3500-5000 tons) are
used for therapy and disease prevention in human medicine and
about 50000 tons for treatment and growth promotion in the
livestock and agriculture sectors. Estimates were >100,000
tonnes of antibiotics used in livestock (OIE, 2019).
However, the Centre for Disease Dynamics, Economics & Policy
(CDEEP, 2021) found that in 2013, the global consumption of all
antimicrobials in food animals was 131,109 tonnes and is
projected to reach 200,235 tonnes by 2030.
CDDEP report, global antibiotic consumption increased by 65%
between 2000 and 2015, and the rate of antibiotic consumption
increased by 39%, 32 from 11.3 to 15.7 defined daily doses
(DDDs) per 1,000 people.
From 2000 to 2015: Globally, total antibiotic consumption in humans
soared 65%. In India 103% increase, China 79%, and in Pakistan
65% increase (Center for Disease Dynamics, Economics & Policy, 2018).
9. Herbal antimicrobials
Bhardwaj et al., 2016. Pharmaceutica Analytica Acta 7(11):1-4. DOI: 10.4172/2153-2435.1000523
ā¢ Alcaloids: Piperine (Pier longum, Piper nigrum), Berberine
(Berberis vulgaris), Reserpine (Rauwolfia serpentina).
ā¢ Organosulphur compounds: Allicin (Allium sativum)
ā¢ Terpenes: Carvone, Eugenol, Linelool, Thymol, Carvacrol
(cymophenol, CāHāCāHā), is a mono-terpenoid phenol.
ā¢ Cinnamaldehyde, CāHā CH=CHCHO is a phenyl-propanoid,
naturally synthesized by the shikimate pathway.
12. 0.00
20.00
40.00
60.00
80.00
100.00
120.00
Tetracycline Susceptible Tetracycline Resistant
Chloramphenicol Susceptible Chloramphenicol Resistant
Tetracycline and chloramphenicol resistant bacteria are more
resistant to herbal antimicrobials than the susceptible strains.
Susceptibility of clinical and environmental bacterial
strains to herbal antimicrobials
13. Susceptibility of clinical and environmental bacterial
strains to herbal antimicrobials
0.00
20.00
40.00
60.00
80.00
100.00
120.00
Ciprofloxacin Susceptible Ciprofloxacin Resistant
Gentamicin Susceptible Gentamicin Resistant
Ciprofloxacin-resistant
bacteria were more often
susceptible to Ajowan oil
than Cipro-susceptible
strains.
Gentamicin-resistant
strains were more
susceptible to Carvacrol
than gentamicin
susceptible strains.
For other herbals Genta
and Cipro-Resisatnt
strains were also more
resistant than susceptible
strains.
14. Susceptibility of clinical and environmental bacterial
strains to herbal antimicrobials
0.00
10.00
20.00
30.00
40.00
50.00
60.00
70.00
80.00
90.00
100.00
Non-ESBL Producers ESBL Producers
ESBL Producers Carbapenem Resistant Non ESBL Producers Carbapenem Susceptible
ESBL producing bacteria
were more susceptible than
non-ESBL producers to
Ajowan oil, HBO,
Cinnamaldehyde, Thyme
oil, & Cinnamon oil.
Strains not producing ESBL
and susceptible to
carbapenems were more
resistant to Ajowan oil than
strains resistant to
carbapenems and
15. Susceptibility of clinical and environmental bacterial
strains to herbal antimicrobials
0.00
20.00
40.00
60.00
80.00
100.00
120.00 Nitrofurantoin Susceptible Nitrofurantoin Resistant
Carbapenem Susceptible Carbapenem Resistant Nitrofurantoin or
carbapenem
susceptible strains
were more often
susceptible to herbal
antimicrobials than
nitrofurnatoin or
carbapenem resistant
strains
17. Limitation of Herbal antimicrobial therapy
ā¢ Quality, and Quality control: No or only
preliminary
ā¢ Availability in required quality and quantity
ā¢ Therapeutic doses ill-defined.
ā¢ Lack of Evidence-based literature.
ā¢ Systemic use problems
ā¢ Safety and toxicity problems
ā¢ No standard Pharmacopeia
ā¢ Herbal drug resistance and cross-resistance to
antibiotics.
ā¢ Misconceptions
18. Strength and weakness of Herbal
Antimicrobials
ā¢ Some are really very effective antimicrobials even more than the
best antibiotics.
ā¢ Corrosive/ irritant/ non-soluble in an aqueous system.
ā¢ Herbal antimicrobials lose antimicrobial potential when added
with common excipients like blending oils/ ointment bases. The
two most potent herbal antimicrobials, Thyme and Ajwain oils (2%),
completely lost their antibacterial activity in vegetable oils and
liquid paraffin. However, Cinnamon oil, another potent herbal
antimicrobial, lost its antimicrobial activity significantly in all the
excipients compared to Dimethyl-Sufoxide as a diluent. Among
vegetable oils, olive oil followed by palm oil, mustard oil, sesame oil
and coconut oil retained the antimicrobial activity of cinnamon oil
to a variable extent.
https://www.researchgate.net/publication/351761448_Excipient_effec
t_on_antimicrobial_activity_of_cinnamon_Cinnamomum_zelylanic
um_album_oil_thyme_Thymus_vulgaris_oil_and_ajowan_Trachysp
ermum_ammi_oil.
19. Future Research
ā¢ Better delivery systems (non-toxic, targeted):
Nano-formulations
ā¢ Methods for Quality Assurance
ā¢ Clinical studies for dose and regimen
standardization